Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Exelixis Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
EXEL
Nasdaq
2834
https://www.exelixis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Exelixis Inc
Insiders Are Dumping These 10 Healthcare Stocks
- Mar 28th, 2024 12:13 pm
4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
- Mar 23rd, 2024 9:06 am
Exelixis, Inc.'s (NASDAQ:EXEL) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
- Mar 21st, 2024 12:21 pm
30 Biggest Biotechnology Companies in the World
- Mar 17th, 2024 12:50 pm
Why Is Immunovant, Inc. (IMVT) Down 14.7% Since Last Earnings Report?
- Mar 13th, 2024 3:30 pm
The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys
- Mar 11th, 2024 2:36 pm
10 Biotech Stocks with Huge Potential
- Mar 8th, 2024 2:38 pm
2 Biotech Stocks to Buy Hand Over Fist in March
- Mar 8th, 2024 1:15 pm
Why Is Exelixis (EXEL) Up 10.9% Since Last Earnings Report?
- Mar 7th, 2024 4:31 pm
10 Mid-Cap Stocks with Insider Purchases
- Mar 7th, 2024 3:08 pm
3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success
- Mar 6th, 2024 9:45 pm
EXEL vs. REGN: Which Stock Is the Better Value Option?
- Mar 6th, 2024 4:40 pm
4 Thrilling Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
- Mar 2nd, 2024 10:06 am
ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?
- Mar 1st, 2024 2:15 pm
Is Now The Time To Put Exelixis (NASDAQ:EXEL) On Your Watchlist?
- Feb 29th, 2024 7:57 pm
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in March
- Feb 27th, 2024 9:05 pm
Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments
- Feb 27th, 2024 1:00 pm
2 Stocks Under $30 to Buy and Hold
- Feb 19th, 2024 1:00 pm
Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology
- Feb 14th, 2024 11:00 am
Jim Simons Increases Stake in Exelixis Inc
- Feb 14th, 2024 6:47 am
Scroll